The quasicrystalline phase forming ability, solidification structure, thermal stability, and phase relationships of a series of conventionally-cast Al62-xCu25.5Fe12.5Bex (x=0,1,3,5,7) alloys were investigated. Single icosahedral quasicrystalline phase was successfully obtained by partial replacement of Al with Be (7 at.%) in an Al62Cu25.5Fe12.5 alloy during crucible cooling. The I-phase in an Al55Cu25.5Fe12.5Be7 alloy has the same face-centered icosahedral structure as that in an Al62Cu25.5Fe12.5 alloy, with less phason strain. Hardness of the I-phase increases with x, i.e. from Hv 710 for x=1 to Hv 809 for x=7.
Alkali oxides were added to glass frit in order to lower the firing temperature of dental
porcelain, and the effects of Li2O and B2O3 on the thermal properties and chemical solubility of low-fusing dental porcelain were investigated.
The glass transition temperature(Tg) and softening temperature(Ts) of glass frits were decreased remarkably by adding Li2O, but the coefficient of thermal expansion(CTE) was increased with Li2O. In the case of adding B2O3, the thermal properties were unchanged. Tg of B0L4, B2L4 and B4L4 specimens were lower than 500°C and Ts were lower than 550°C. The chemical solubility of prepared low-fusing dental porcelain with these glass frits were 37.3,
43.9, and 49.2µg·cm-2 respectively. The chemical solubility was increased by adding Li2O and B2O3, but all the results were below 100µg·cm-2 and satisfactory to ISO Standards. Further, the chemical solubility of the commercial low-fusing dental porcelains were 52.6µg·cm-2 for Ceramco Finesse(Clear), 70.8µg·cm-2 for Duceram-LFC(TC) and that of conventional dental porcelain, CeraMax(T-C), was 34.8µg·cm-2.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.